
Stephen Gucker
Examiner (ID: 445)
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1647, 1812, 1818, 1646, 1645 |
| Total Applications | 799 |
| Issued Applications | 370 |
| Pending Applications | 114 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6213880
[patent_doc_number] => 20110136742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'ANTIDEPRESSANT PRODRUGS'
[patent_app_type] => utility
[patent_app_number] => 12/280190
[patent_app_country] => US
[patent_app_date] => 2007-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5128
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136742.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280190
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280190 | ANTIDEPRESSANT PRODRUGS | Feb 21, 2007 | Abandoned |
Array
(
[id] => 4977258
[patent_doc_number] => 20070218491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Oligomerization of amyloid proteins'
[patent_app_type] => utility
[patent_app_number] => 11/704079
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6917
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218491.pdf
[firstpage_image] =>[orig_patent_app_number] => 11704079
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/704079 | Oligomerization of amyloid proteins | Feb 7, 2007 | Abandoned |
Array
(
[id] => 5004984
[patent_doc_number] => 20070202554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Method for determining degree of negative effect of macrophages on vertebrate'
[patent_app_type] => utility
[patent_app_number] => 11/699018
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2887
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202554.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699018
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699018 | Method for determining degree of negative effect of macrophages on vertebrate | Jan 28, 2007 | Issued |
Array
(
[id] => 4846376
[patent_doc_number] => 20080182784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/627005
[patent_app_country] => US
[patent_app_date] => 2007-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20850
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182784.pdf
[firstpage_image] =>[orig_patent_app_number] => 11627005
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/627005 | Methods and compositions for treating neurological disorders | Jan 24, 2007 | Issued |
Array
(
[id] => 5580526
[patent_doc_number] => 20090175872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Treatment of Conditions Involving Demyelination'
[patent_app_type] => utility
[patent_app_number] => 12/095857
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 49491
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175872.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095857
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095857 | Treatment of Conditions Involving Demyelination | Nov 30, 2006 | Abandoned |
Array
(
[id] => 6425421
[patent_doc_number] => 20100151451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'Method for Identifying the Genotype in Position 171 of the Ovine Prion Protein as well as Kits for Implementing said Method'
[patent_app_type] => utility
[patent_app_number] => 12/095058
[patent_app_country] => US
[patent_app_date] => 2006-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10708
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151451.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095058
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095058 | Method for Identifying the Genotype in Position 171 of the Ovine Prion Protein as well as Kits for Implementing said Method | Nov 23, 2006 | Abandoned |
Array
(
[id] => 5435572
[patent_doc_number] => 20090170159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'PRODUCTION OF GLYCOPROTEINS WITH REDUCED O-GLYCOSYLATION'
[patent_app_type] => utility
[patent_app_number] => 12/084591
[patent_app_country] => US
[patent_app_date] => 2006-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14772
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170159.pdf
[firstpage_image] =>[orig_patent_app_number] => 12084591
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/084591 | Production of glycoproteins with reduced O-glycosylation | Nov 9, 2006 | Issued |
Array
(
[id] => 5130755
[patent_doc_number] => 20070207152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Human BNP immunospecific antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/595625
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 30277
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207152.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595625
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595625 | Human BNP immunospecific antibodies | Nov 8, 2006 | Abandoned |
Array
(
[id] => 91778
[patent_doc_number] => 07732201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Method for production of neuroblasts'
[patent_app_type] => utility
[patent_app_number] => 11/592504
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 17
[patent_no_of_words] => 13940
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732201.pdf
[firstpage_image] =>[orig_patent_app_number] => 11592504
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/592504 | Method for production of neuroblasts | Nov 2, 2006 | Issued |
Array
(
[id] => 5183607
[patent_doc_number] => 20070054961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Factor'
[patent_app_type] => utility
[patent_app_number] => 11/526458
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21272
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054961.pdf
[firstpage_image] =>[orig_patent_app_number] => 11526458
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/526458 | Factor | Sep 24, 2006 | Abandoned |
Array
(
[id] => 5095513
[patent_doc_number] => 20070117122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Methods of diagnosing or prognosticating age-related macular degeneration'
[patent_app_type] => utility
[patent_app_number] => 11/526188
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12491
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117122.pdf
[firstpage_image] =>[orig_patent_app_number] => 11526188
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/526188 | Methods of diagnosing or prognosticating age-related macular degeneration | Sep 24, 2006 | Abandoned |
Array
(
[id] => 5074819
[patent_doc_number] => 20070014794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'METHOD FOR MAKING HETEROMULTIMERIC POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 11/533709
[patent_app_country] => US
[patent_app_date] => 2006-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22619
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014794.pdf
[firstpage_image] =>[orig_patent_app_number] => 11533709
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/533709 | Knobs and holes heteromeric polypeptides | Sep 19, 2006 | Issued |
Array
(
[id] => 7795370
[patent_doc_number] => 08124076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Single chain antibodies against β-amyloid peptide'
[patent_app_type] => utility
[patent_app_number] => 12/064144
[patent_app_country] => US
[patent_app_date] => 2006-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 6658
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124076.pdf
[firstpage_image] =>[orig_patent_app_number] => 12064144
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/064144 | Single chain antibodies against β-amyloid peptide | Aug 17, 2006 | Issued |
Array
(
[id] => 5662504
[patent_doc_number] => 20060253100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Systems and Methods to Treat Pain Locally'
[patent_app_type] => utility
[patent_app_number] => 11/460012
[patent_app_country] => US
[patent_app_date] => 2006-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8126
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20060253100.pdf
[firstpage_image] =>[orig_patent_app_number] => 11460012
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/460012 | Systems and Methods to Treat Pain Locally | Jul 25, 2006 | Abandoned |
Array
(
[id] => 5570240
[patent_doc_number] => 20090253618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'NEURONAL DIFFERENTIATION-INDUCING PEPTIDE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/996207
[patent_app_country] => US
[patent_app_date] => 2006-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9469
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253618.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996207
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996207 | NEURONAL DIFFERENTIATION-INDUCING PEPTIDE AND USE THEREOF | Jul 19, 2006 | Abandoned |
Array
(
[id] => 4711678
[patent_doc_number] => 20080300204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Alpha-Synuclein Antibodies and Methods Related Thereto'
[patent_app_type] => utility
[patent_app_number] => 11/996262
[patent_app_country] => US
[patent_app_date] => 2006-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 27771
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300204.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996262
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996262 | Alpha-Synuclein Antibodies and Methods Related Thereto | Jul 18, 2006 | Abandoned |
Array
(
[id] => 5022696
[patent_doc_number] => 20070148662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Prostate-specific membrane antigen'
[patent_app_type] => utility
[patent_app_number] => 11/480319
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 12724
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11480319
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/480319 | Prostate-specific membrane antigen | Jun 29, 2006 | Abandoned |
Array
(
[id] => 6212329
[patent_doc_number] => 20110135629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 11/993130
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17846
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20110135629.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993130
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993130 | EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use | Jun 19, 2006 | Abandoned |
Array
(
[id] => 7683787
[patent_doc_number] => 20100122354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'CDC6S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 11/993122
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17847
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20100122354.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993122
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993122 | CDC6S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE | Jun 19, 2006 | Abandoned |
Array
(
[id] => 6367886
[patent_doc_number] => 20100074884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'INHIBITION OF NEURONAL DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 11/916237
[patent_app_country] => US
[patent_app_date] => 2006-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8933
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20100074884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916237
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916237 | INHIBITION OF NEURONAL DAMAGE | May 30, 2006 | Abandoned |